Vitamin Shoppe, Inc (NYSE:VSI) Director John D. Bowlin acquired 40,000 shares of the business’s stock in a transaction on Friday, August 25th. The shares were bought at an average price of $5.50 per share, for a total transaction of $220,000.00. Following the acquisition, the director now owns 56,028 shares in the company, valued at approximately $308,154. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of Vitamin Shoppe, Inc (NYSE VSI) opened at 5.00 on Wednesday. The stock’s 50 day moving average price is $8.98 and its 200-day moving average price is $14.78. Vitamin Shoppe, Inc has a 52-week low of $4.95 and a 52-week high of $28.41. The firm’s market cap is $116.12 million.

Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing analysts’ consensus estimates of $0.39 by $0.16. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The company had revenue of $304.84 million during the quarter, compared to the consensus estimate of $314.74 million. During the same period in the prior year, the firm earned $0.55 earnings per share. The business’s revenue for the quarter was down 8.4% compared to the same quarter last year. On average, analysts forecast that Vitamin Shoppe, Inc will post $0.79 EPS for the current year.

WARNING: This piece of content was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of US and international copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/30/vitamin-shoppe-inc-vsi-director-john-d-bowlin-acquires-40000-shares-of-stock.html.

Hedge funds have recently modified their holdings of the company. Point72 Asset Management L.P. bought a new stake in shares of Vitamin Shoppe during the first quarter worth approximately $11,515,000. FMR LLC boosted its stake in shares of Vitamin Shoppe by 32.4% in the second quarter. FMR LLC now owns 1,254,690 shares of the specialty retailer’s stock worth $14,617,000 after buying an additional 307,050 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Vitamin Shoppe by 14.8% in the first quarter. Vanguard Group Inc. now owns 2,186,549 shares of the specialty retailer’s stock worth $44,059,000 after buying an additional 282,598 shares in the last quarter. Olstein Capital Management L.P. boosted its stake in shares of Vitamin Shoppe by 22.9% in the first quarter. Olstein Capital Management L.P. now owns 802,133 shares of the specialty retailer’s stock worth $16,163,000 after buying an additional 149,338 shares in the last quarter. Finally, Barrow Hanley Mewhinney & Strauss LLC boosted its stake in shares of Vitamin Shoppe by 6.8% in the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 1,910,081 shares of the specialty retailer’s stock worth $38,488,000 after buying an additional 122,445 shares in the last quarter. 96.86% of the stock is currently owned by hedge funds and other institutional investors.

VSI has been the topic of a number of research reports. Zacks Investment Research downgraded Vitamin Shoppe from a “hold” rating to a “sell” rating in a report on Wednesday, May 3rd. Morgan Stanley raised Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 price target for the company in a research note on Thursday, May 11th. Gabelli cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. Barclays PLC reaffirmed an “equal weight” rating and set a $13.00 target price (down previously from $24.00) on shares of Vitamin Shoppe in a research report on Sunday, May 14th. Finally, ValuEngine cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Four research analysts have rated the stock with a sell rating and seven have given a hold rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $14.38.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Receive News & Stock Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related stocks with our FREE daily email newsletter.